❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Microbiology ❭ Genome and Epigenome Regulation in Embryo Development, Ageing and Disease [Dahl] ❭ Funding agencies ❭

Our research is funded by:

The Research Council of Norway

  • FRIPRO
  • BEDRE BEHANDLING

The Norwegian Cancer Society

The South-Eastern Norway Regional Health Authority

UiO:LifeScience
(http://www.uio.no/english/research/strategic-research-areas/life-science/)

Anders Jahres fond til vitenskapens fremme (MEDISIN)

 

 
Scroll to top

Home Dept. of Microbiology Genome and Epigenome Regulation in Embryo Development, Ageing and Disease [Dahl]

  • Group members
  • Projects
  • Publications
  • Available positions
  • Funding agencies
  • Collaborations
  • News

Recent publications

Ellingjord-Dale M, Nygaard AB, Støer NC, Bø R, Landrø NI, Brunvoll SH, Istre M, Kalleberg KT, Dahl JA, Geng L, Tsilidis K, Riboli E, Ursin G, Søraas A (2024)
Temporal trajectories of long-COVID symptoms in adults with 22 months follow-up in a prospective cohort study in Norway
Int J Infect Dis, 149, 107263
DOI 10.1016/j.ijid.2024.107263, PubMed 39419167

Halliwell JA, Martin-Gonzalez J, Hashim A, Dahl JA, Hoffmann ER, Lerdrup M (2024)
Sex-specific DNA-replication in the early mammalian embryo
Nat Commun, 15 (1), 6323
DOI 10.1038/s41467-024-50727-w, PubMed 39060312

Søraas A, Brunvoll SH, Nygaard AB, Dahl JA, Ursin G (2024)
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan
Lancet, 403 (10434), 1336
DOI 10.1016/S0140-6736(24)00414-8, PubMed 38582558

More

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)